ArticleJournal for immunotherapy of cancer2019

Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager.

Jana de Sostoa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.